Evaluating Relationships between Visceral Fat Measures and Adipokines Concentrations among Women with a History of Preeclampsia
Objective We sought to evaluate associations between postpartum plasma adipokine concentrations among women with a history of preeclampsia (PE) without severe features (MPE), PE with severe features (SPE), and no PE (NPE). We also investigated relationships between adipokines and computed tomography (CT)-quantified measures of visceral fat (VF) area (VFA) and subcutaneous fat area (SCFA).
Study Design We performed a secondary analysis of data collected as part of a previously performed cross-sectional study at our institution. Women with and without a history of PE were recruited in 10 years after delivery. VFA and SCFA measures were performed by CT scan. Anthropometric data and peripheral blood samples from subjects were collected concurrently.
Results Plasma adiponectin concentrations (µg/mL) were significantly lower among MPE (18.5 ± 7.1) compared with NPE (27.3 ± 13.8) and SPE (25.7 ± 9.6). Leptin (p = 0.32) and resistin (p = 0.93) concentrations were similar among the groups. Adiponectin concentrations more closely aligned with VFA (β = −0.001, p = 0.03), while resistin concentrations trended toward correlating with SCFA (β = 0.02, p = 0.05). Leptin was not preferential to VFA or SCFA.
Conclusion VF distribution may contribute to the variation in PE phenotype. Adiponectin specifically may be a promising marker representing VFA.
Received: 21 December 2018
Accepted: 06 May 2019
06 June 2019 (online)
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
- 1 American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 125: chronic hypertension in pregnancy. Obstet Gynecol 2012; 119 (2 Pt 1): 396-407
- 2 American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
- 3 D'Alton ME, Main EK, Menard MK, Levy BS. The national partnership for maternal safety. Obstet Gynecol 2014; 123 (05) 973-977
- 4 Fingar KR, Mabry-Hernandez I, Ngo-Metzger Q, Wolff T, Steiner CA, Elixhauser A. Delivery Hospitalizations Involving Preeclampsia and Eclampsia, 2005–2014: Statistical Brief #222. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006
- 5 Dietz WH. The response of the US Centers for Disease Control and Prevention to the obesity epidemic. Annu Rev Public Health 2015; 36: 575-596
- 6 Overcash RT, Lacoursiere DY. The clinical approach to obesity in pregnancy. Clin Obstet Gynecol 2014; 57 (03) 485-500
- 7 Roberts JM, Bodnar LM, Patrick TE, Powers RW. The role of obesity in preeclampsia. Pregnancy Hypertens 2011; 1 (01) 6-16
- 8 Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med 2010; 15 (02) 70-76
- 9 Rasmussen KM, Abrams B, Bodnar LM, Butte NF, Catalano PM, Maria Siega-Riz A. Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol 2010; 116 (05) 1191-1195
- 10 Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr Opin Obstet Gynecol 2009; 21 (06) 521-526
- 11 Weiss JL, Malone FD, Emig D. , et al; FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol 2004; 190 (04) 1091-1097
- 12 Barry DR, Utzschneider KM, Tong J. , et al. Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia. Am J Obstet Gynecol 2015; 213 (01) 104.e1-104.e11
- 13 Kanai H, Tokunaga K, Fujioka S, Yamashita S, Kameda-Takemura KK, Matsuzawa Y. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 1996; 27 (01) 125-129
- 14 Diaz AA, Young TP, Kurugol S. , et al; COPDGene investigators. Abdominal visceral adipose tissue is associated with myocardial infarction in patients with COPD. Chronic Obstr Pulm Dis (Miami) 2015; 2 (01) 8-16
- 15 Katsuki A, Sumida Y, Urakawa H. , et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003; 26 (08) 2341-2344
- 16 Utzschneider KM, Carr DB, Hull RL. , et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes 2004; 53 (11) 2867-2872
- 17 Taylor RW, Goulding A. Plasma leptin in relation to regional body fat in older New Zealand women. Aust N Z J Med 1998; 28 (03) 316-321
- 18 Schur EA, Melhorn SJ, Oh SK. , et al. Radiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans. Obesity (Silver Spring) 2015; 23 (11) 2142-2148
- 19 Schwartz RS, Shuman WP, Larson V. , et al. The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism 1991; 40 (05) 545-551
- 20 Bosch TA, Chow L, Dengel DR. , et al. In adult twins, visceral fat accumulation depends more on exceeding sex-specific adiposity thresholds than on genetics. Metabolism 2015; 64 (09) 991-998
- 21 Doster Y, Cetinkaya Demir B, Atalay MA, Durusoy EE, Kucukkomurcu S. The possible role of serum leptin in preeclampsia. Clin Exp Obstet Gynecol 2016; 43 (01) 98-102
- 22 Martínez-Abundis E, González-Ortiz M, Pascoe-González S. Serum leptin levels and the severity of preeclampsia. Arch Gynecol Obstet 2000; 264 (02) 71-73
- 23 Koçyigit Y, Atamer Y, Atamer A, Tuzcu A, Akkus Z. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 2004; 19 (05) 267-273
- 24 Kocyigit Y, Bayhan G, Atamer A, Atamer Y. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 2004; 18 (06) 341-348
- 25 Williams MA, Havel PJ, Schwartz MW. , et al. Pre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women. Paediatr Perinat Epidemiol 1999; 13 (02) 190-204
- 26 Hendler I, Blackwell SC, Mehta SH. , et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 2005; 193 (3 Pt 2): 979-983
- 27 Iftikhar U, Khoja A, , Mehjabeen, Iqbal A, Karira KA. Evaluation of serum leptin levels during normal pregnancy and in pre-eclampsia. J Ayub Med Coll Abbottabad 2008; 20 (04) 137-140
- 28 Mumtaz F, Memon AR, Yousfani S. , et al. Role of serum leptin level as a marker of severity of pre eclampsia. J Ayub Med Coll Abbottabad 2008; 20 (01) 13-15
- 29 Song Y, Gao J, Qu Y, Wang S, Wang X, Liu J. Serum levels of leptin, adiponectin and resistin in relation to clinical characteristics in normal pregnancy and preeclampsia. Clin Chim Acta 2016; 458: 133-137
- 30 Founds SA, Tsigas E, Ren D, Barmada MM. Associating symptom phenotype and genotype in preeclampsia. Biol Res Nurs 2018; 20 (02) 126-136
- 31 Fong FM, Sahemey MK, Hamedi G. , et al. Maternal genotype and severe preeclampsia: a HuGE review. Am J Epidemiol 2014; 180 (04) 335-345
- 32 Huda SS, Jordan F, Bray J. , et al. Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancys. Clin Sci (Lond) 2017; 131 (13) 1529-1540
- 33 Bro Schmidt G, Christensen M, Breth Knudsen U. Preeclampsia and later cardiovascular disease - what do national guidelines recommend?. Pregnancy Hypertens 2017; 10: 14-17
- 34 Brouwers L, van der Meiden-van Roest AJ, Savelkoul C. , et al. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG 2018; 125 (13) 1642-1654
- 35 Lisowska M, Pietrucha T, Sakowicz A. Preeclampsia and related cardiovascular risk: common genetic background. Curr Hypertens Rep 2018; 20 (08) 71